WHAT IS HEART DISEASE?
Cardiovascular diseases (CVDs) such as angina, deep vein thrombosis and hypertension are caused by abnormalities in various biological pathways due to a complex interaction between genes and the environment.
A multi-gene test was developed to help identify CVD subtypes that require
different treatment strategies for effective intervention. It improves
diagnostic reliability and defines the clinical, biochemical, genetic
and environmental risk components as contributing factors to CVD risk.
The gene variations included in the test are important contributing factors to dyslipidaemia, thrombophilia, or altered nutrient requirements that may lead to abnormal blood levels (e.g. homocysteine, serum iron status) in the presence of (modifiable) environmental triggers. This test is performed in conjunction with a medical and lifestyle assessment to determine gene expression as reflected by biochemical abnormalities that in turn could be used to monitor response to treatment.
Combining service with research:
genetic testing service is combined with an ethically approved research
project to enable us to
monitor the success of a wellness initiative in collaboration with the
referring clinician. Patients will be assisted to sign the
research informed consent form that may be be provided together with a
sample collection kit. EDTA blood (purple top tube) can also be
provided for DNA testing when the informed consent form is downloaded
from this website.
Patients are encouraged to contact
Professor Maritha Kotze (firstname.lastname@example.org / email@example.com; tel. 27 21 9389324 / 0828799108) with any questions they may have about the research or test-related payment.
A quote for the amount due will be emailed to you once the service
request has been entered online. Please provide the contact
details of the consulting healthcare practitioner for participation.